
Viela Bio, Inc. VIE
Viela Bio, Inc. Operating Cycle 2011-2026 | VIE
Annual Operating Cycle Viela Bio, Inc.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 174 | 177 | 181 | 168 | 161 | 137 | 114 | 121 | 143 | 132 | 135 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 181 | 114 | 149 |
Operating Cycle of other stocks in the Biotechnology industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Xeris Pharmaceuticals
XERS
|
558 | $ 6.03 | -1.55 % | $ 885 M | ||
|
I-Mab
IMAB
|
271 | - | - | $ 866 M | ||
|
UroGen Pharma Ltd.
URGN
|
465 | $ 19.2 | -11.52 % | $ 554 M | ||
|
uniQure N.V.
QURE
|
19.4 K | $ 10.89 | -30.36 % | $ 530 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
AbCellera Biologics
ABCL
|
173 | $ 3.74 | 3.6 % | $ 1.12 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
32 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
245 | - | -18.52 % | $ 27.3 M | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | ||
|
Acorda Therapeutics
ACOR
|
394 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
Aeterna Zentaris
AEZS
|
115 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
78.4 | - | -10.17 % | $ 12.2 K | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | ||
|
Agenus
AGEN
|
4.13 | $ 3.36 | 0.86 % | $ 1.2 M | ||
|
Ayala Pharmaceuticals
AYLA
|
61.7 | - | - | $ 7.46 M | ||
|
Agios Pharmaceuticals
AGIO
|
1.74 K | $ 29.16 | -3.54 % | $ 1.69 B | ||
|
Advaxis
ADXS
|
88.1 | - | -9.65 % | $ 45.9 M | ||
|
Завод ДИОД
DIOD
|
64.6 | - | - | - | ||
|
Фармсинтез
LIFE
|
9.78 | - | - | - | ||
|
Albireo Pharma
ALBO
|
40.8 | - | -0.23 % | $ 916 M | ||
|
Altimmune
ALT
|
15.1 K | $ 4.21 | -2.32 % | $ 299 M | ||
|
Teligent, Inc.
TLGT
|
167 | - | -13.85 % | $ 16.1 M | ||
|
Evogene Ltd.
EVGN
|
30 | $ 0.84 | -4.24 % | $ 27.9 M | ||
|
Amarin Corporation plc
AMRN
|
213 | $ 13.98 | 1.27 % | $ 5.7 B | ||
|
AbbVie
ABBV
|
350 | $ 233.57 | 0.64 % | $ 413 B | ||
|
Blueprint Medicines Corporation
BPMC
|
358 | - | - | $ 8.14 B | ||
|
AIM ImmunoTech
AIM
|
46 | $ 0.8 | -11.6 % | $ 38.5 M | ||
|
Aptorum Group Limited
APM
|
4.89 | $ 0.83 | 5.37 % | $ 4.53 M | ||
|
Apellis Pharmaceuticals
APLS
|
115 | $ 20.67 | -1.38 % | $ 2.61 B |